(RTTNews) – Ikena Oncology, Inc. (IKNA) announced that Institutional Shareholder Services – ISS and Glass, Lewis & Co. have recommended shareholders vote in favor of issuing shares for the company’s proposed merger with Inmagene Biopharmaceuticals. The vote will take place during